The small ubiquitin-like modifier protein (SUMO) regulates transcriptional activity and the translocation of proteins across the nuclear membrane 1 . The identification of SUMO substrates outside the nucleus is progressing 2 but little is yet known about the wider cellular role of protein SUMOylation. Here we report that in rat hippocampal neurons multiple SUMOylation targets are present at synapses and we show that the kainate receptor subunit GluR6 is a SUMO substrate. SUMOylation of GluR6 regulates endocytosis of the kainate receptor and modifies synaptic transmission. GluR6 exhibits low levels of SUMOylation under resting conditions and is rapidly SUMOylated in response to a kainate but not an N-methyl-D-aspartate (NMDA) treatment. Reducing GluR6 SUMOylation using the SUMO-specific isopeptidase SENP-1 prevents kainate-evoked endocytosis of the kainate receptor. Furthermore, a mutated non-SUMOylatable form of GluR6 is not endocytosed in response to kainate in COS-7 cells. Consistent with this, electrophysiological recordings in hippocampal slices demonstrate that kainate-receptor-mediated excitatory postsynaptic currents are decreased by SUMOylation and enhanced by deSUMOylation. These data reveal a previously unsuspected role for SUMO in the regulation of synaptic function.
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Kainate receptors (KARs) have key roles in the regulation of synaptic transmission and neuronal excitability in the mammalian brain. At the presynaptic terminal they can modulate neurotransmitter release, and at the postsynaptic membrane they contribute to fast excitatory synaptic transmission 3 . The GluR6 subunit is expressed throughout the brain but is particularly abundant in the hippocampus, where GluR6 subunits can be present in both pre-and postsynaptic KAR complexes 4 . We identified the specific SUMO-conjugating enzyme Ubc9 and the SUMO ligase PIAS3 (Supplementary Figs 1, 2) as GluR6a interactors in a yeast two-hybrid screen. Of the ionotropic glutamate receptor subunits tested, only GluR6a exhibited strong interaction with both enzymes (Fig. 1a) . These interactions were verified by co-immunoprecipitation of Ubc9 and PIAS3 with an anti-GluR6 antibody ( Supplementary Fig. 1b, c) . Truncation mutagenesis mapped the GluR6 interaction domain (Fig. 1b) to residues 882-895 which, alone among the KAR subunits, contains the consensus SUMOylation motif YKXE (ref. 5) .
We next probed subcellular fractions with specific anti-SUMO-1 antibodies (Fig. 1c, Supplementary Figs 3, 5) . Multiple SUMOconjugated proteins were detected in all fractions, including high levels in the synaptosomal and postsynaptic density fractions (Fig.  1c) . SUMOylation is readily reversible 6 , so we assessed the effects of the cysteine isopeptidase inhibitor N-ethylmaleimide (NEM) 7 . Detection of SUMOylated proteins was markedly reduced in the absence of NEM (Supplementary Fig. 3a) . Furthermore, in brain extracts a distinct higher-molecular-mass GluR6 band was detected in the presence of NEM (Fig. 1d) . A specific GluR6 band was also detected in anti-SUMO antibody immunoprecipitates from cultures (Fig. 1e, Supplementary Fig. 5a ) further confirming that GluR6 is SUMOylated in hippocampal neurons. As a control, the known SUMO substrate RanGAP1 was also retrieved in SUMO immunoprecipitates ( Supplementary Fig. 4a, c) . Interestingly, however, SUMOylated surface-expressed GluR6 was not detected in resting cultured neurons (Fig. 1e) . Consistent with the yeast two-hybrid data, no corresponding band shift in the presence of NEM was observed for the AMPA receptor subunit GluR1 (Fig. 1e , Supplementary Fig. 4b ).
As expected, we found high levels of SUMO immunoreactivity in the nucleus of cultured neurons. SUMO immunoreactivity was also distributed throughout dendrites (Fig. 1f-h) , where it displayed a punctate distribution similar to those of GluR6, Ubc9 and PIAS3 ( Supplementary Fig. 1d , e) and was present at PSD95-positive synapses ( Supplementary Fig. 2a, b) . Under basal conditions there were low levels of colocalization of surface-expressed GluR6 and SUMO-1 (5.3 6 0.8%) but there was some limited overlap between total GluR6 and SUMO-1 immunoreactivity (28.6 6 1.5%; Fig. 1f-h ), indicating that most SUMOylated GluR6 is intracellular. The low level of colocalization between surface GluR6 and SUMO-1 is consistent with only a small fraction of substrate being SUMOylated at any given time 6, 8 . Application of kainate or NMDA evokes internalization of GluR6 into distinct sorting pathways 9 . We therefore tested the effects of these agonists on GluR6 SUMOylation in immunoprecipitation experiments. Kainate (10 mM) rapidly increased the low basal level of GluR6 SUMOylation (Fig. 2a, b) . This was detectable after 1 min (data not shown), increased .2-fold (2.4 6 0.4, P , 0.001) at 3 min and reached maximal conjugation within 10 min (3.4 6 0.4, P , 0.001). Glutamate (1 mM) also had similar effects ( Supplementary  Fig. 6 ). Despite strong NMDA-evoked internalization 9 there was no increase in GluR6 SUMOylation (Fig. 2a, b) . Neither kainate nor NMDA altered global cellular SUMOylation (Supplementary Fig.  7 ). Similarly, in immunocytochemical assays colocalization between SUMO-1 and internalized GluR6 was 46.7 6 3.0% at 3 min and 54.1 6 4.9% at 30 min after adding kainate but only 15.9 6 1.8% at 3 min and 16.7 6 1.7% at 30 min after adding NMDA (Fig. 2c-h) .
To explore the role of SUMOylation in agonist-evoked GluR6 endocytosis we expressed green fluorescent protein (GFP)-tagged SUMO specific isopeptidase SENP-1 (ref. 10) to facilitate deSUMOylation or its inactive point mutant SENP-1 C603S (ref. 11) (Supplementary Fig. 8 ). SENP-1, but not SENP-1 C603S, prevented kainate-evoked GluR6 internalization but had no effect on NMDA-evoked GluR6 internalization (Fig. 3a, b) . Thus, GluR6 SUMOylation is required for kainate-evoked internalization and probably occurs at the plasma membrane. Because we did not detect SUMOylated GluR6 at the surface (Fig. 1e) we reasoned that internalization occurs rapidly after SUMOylation. Consistent with this, we detected surface-SUMOylated GluR6 in the presence of sucrose that blocks KAR endocytosis (Supplementary Fig. 9 ).
We next made glutathione S-transferase (GST) fusions of wildtype (WT) and K886R GluR6a carboxy-terminal domains for expression in a bacterial SUMOylation assay 12 to determine whether K886 within the consensus SUMOylation motif on GluR6a is the site of SUMOylation. Wild-type, but not K886R, C-terminal GluR6a was robustly SUMOylated (Fig. 3c) . To evaluate the role of K886 neurons. a, The SUMO-conjugating enzyme Ubc9 and the SUMO ligase PIAS3 selectively bind to the C-terminal domain of GluR6a in the yeast twohybrid assay. The C termini of none of the other ionotropic glutamate receptor subunits tested interact strongly with both enzymes, as determined by b-galactosidase reporter activation. b, A series of overlapping truncation mutants of the C terminus of GluR6a tested in the yeast two-hybrid assay showed that the domain for both SUMOylation enzymes contains the consensus SUMOylation motif (YKXE, where Y is the hydrophobic residue). c, Immunoblot (IB) analysis of synaptic SUMOylated proteins after rat brain fractionation. Multiple SUMOylated substrates are present in the synaptic fractions. Equal amount of protein (40 mg protein per lane) from each fraction was loaded. P1, crude nuclear fraction; P2, post-nuclear crude membrane fraction; S3, cytosol; P3, microsomes; My, myelin; Mt, mitochondria; Syn, synaptosomes; PSD, post-synaptic density fraction. Immunoblot probed with anti-PSD95 antibody is shown below (2 mg protein per lane). We note that the PSD95 blot is loaded with very low levels of protein to avoid saturation of the signal in the highly enriched synaptic and postsynaptic density fraction lanes. d, Immunoblots showing SUMOylated and non-SUMOylated forms of GluR6a in brain homogenate. Note that, in the absence of the cysteine protease inhibitor NEM, no detectable band corresponding to SUMOylated GluR6a was observed, which confirms that the SUMO adduct is highly labile and sensitive to de-conjugation. e, Immunoblots showing SUMOylated and non-SUMOylated forms of GluR6a in cultured hippocampal neurons. Immunoprecipitation (IP) experiments using anti-SUMO-1 antibody reveal that a fraction of GluR6a is SUMOylated in cultured hippocampal neurons (right panel). IgG, immunoglobulin. The blots are representative of at least four separate experiments. f, g, Infrequent but punctate colocalization of surface (f) and total GluR6 (g) with total SUMO (in green) in unstimulated cultured hippocampal neurons. We note that SUMO is highly concentrated in the nuclear compartment, consistent with its described role in nuclear function, but also clearly show a punctate distribution along the dendrites. Arrowheads denote colocalization. Scale bar, 20 mm. h, Quantification of surface and total GluR6 receptor population that colocalize with total SUMO-1 in unstimulated cultured hippocampal neurons as shown in f and g. Puncta corresponding to GluR6 that colocalized with the SUMO-1 labelling were quantified using the LSM510 version 3.2 software (Zeiss). Analysis was made from at least eight cells for each condition and given as a percentage 6 s.e.m.
SUMOylation in KAR endocytosis we compared the properties of the wild-type and K886R-tagged GluR6a tagged with yellow fluorescent protein (YFP). Both wild-type and K886R YFP-GluR6a display similar functional channel properties in COS-7 cells (data not shown). Wild-type YFP-GluR6a was surface-expressed in African green monkey kidney (COS-7) cells with minimal colocalization with SUMO-1 in unstimulated cells (Fig. 3d) . Kainate caused a dramatic loss of surface YFP-GluR6a and strong colocalization with SUMO-1 in perimembrane compartments (Fig. 3e) . YFP-GluR6a-K886R also trafficked to the plasma membrane (Fig. 3f) but its distribution was unchanged by kainate (Fig. 3f, g ). The requirement of K886 for kainate-evoked internalization was further confirmed by surface biotinylation (Fig. 3h, i) and antibody feeding experiments (Supplementary Fig. 10 ). Kainate evoked massive endocytosis of wild-type YFP-GluR6a (72.9 6 1.8% at 30 min) but YFP-GluR6a-K886R internalization remained the same as constitutive endocytosis under non-stimulated conditions (12.4 6 0.6% compared to 11.3 6 0.9% in the presence of kainate at 30 min).
To identify a physiological role for GluR6 SUMOylation we investigated postsynaptic KARs at the mossy fibre synapse [13] [14] [15] . Under basal conditions stable, pharmacologically isolated, KAR-mediated, synaptically evoked excitatory postsynaptic currents (KAR-EPSCs) were recorded from CA3 neurons in hippocampal slices (Fig. 4a) . Infusion of SUMO-1 into the CA3 neuron caused a rapid reduction in KAR-EPSC amplitude (97 6 5% and 77 6 8%; control versus SUMO-1; P , 0.05). The conjugation-inactive mutant SUMO-1-DGG had no effect (100 6 6% and 77 6 6%; SUMO-1-DGG versus SUMO-1; P , 0.05) (Fig. 4a, b, g ). Infusion of recombinant SENP-1 increased the KAR-EPSC (98 6 11% and 145 6 13%; control versus SENP-1; P , 0.05). Infusion of the inactive SENP-1 C603S mutant had no effect (91 6 11% and 145 6 21%; SENP-1 C603S versus SENP-1; P , 0.05) (Fig. 4c, d, g ). AMPA-receptor-mediated EPSCs recorded at the same synapse were unaffected by SUMO-1 or SENP-1 (89 6 9% and 101 6 13%; control versus SUMO-1; 101 6 18% and 91 6 13%; control versus SENP-1; Fig. 4e-g ) or at CA1 Schaffer collateral synapses ( Supplementary Fig. 11 ). KAR-EPSC decay kinetics were also unchanged by SUMO-1 (t 5 30.3 6 2.1 ms during first 2 min of recording and 28.9 6 1.7 ms during last 5 min, n 5 11) or SENP-1 (t 5 26.8 6 2.1 ms during first 2 min of recording and 25.6 6 1.6 ms during last 5 min, n 5 11).
We also infused SUMO-1 for 10 min before synaptic stimulation to determine whether SUMO-1 conjugation alone is sufficient to induce a decrease in KAR-EPSC amplitude. After the 10 min delay the reduction in KAR-EPSC amplitude was similar to those recorded immediately after membrane rupture (Fig. 4h) , indicating that this process is activity-dependent because both SUMO-1 and agonist binding are required for the EPSC depression.
Our data indicate that the coincident action of agonist binding and SUMOylation to surface GluR6a leads to the rapid endocytosis of KARs. The observation that SENP-1 causes an increase in KAR-EPSC amplitude implies that when the removal of KARs is inhibited there is exocytosis and lateral diffusion of KARs into the synapse, as shown for AMPA receptors 16, 17 . Also, NMDA stimulated GluR6 endocytosis is SUMO-1 independent, so there must be multiple KAR endo-and exocytosis pathways.
SUMO-1 regulation of KARs may be important in regulating the response of neurons to glutamate release under conditions such as ischaemia. Interestingly, it has been shown that SUMO-1 messenger RNA levels are dramatically raised in ischaemic cells 18 . Because GluR6 is chronically downregulated by excitotoxic stress via a c-fos dependent mechanism 19 , one attractive possibility is that upregulation of SUMO levels leads to a downregulation in KARs, thereby reducing neuronal excitability. The mechanisms by which SUMOylation of GluR6 leads to internalization are unclear, but it seems likely that regulation of interacting proteins 20, 21 may be involved.
Our findings, taken together with the diverse range of functions that SUMO serves in the nucleus and cytoplasm, suggest that this covalent protein modification is likely to regulate the functions of many different synaptic proteins. We anticipate that synaptic 
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SUMOylation represents a novel mechanism that will have farreaching implications for understanding synaptic function.
METHODS SUMMARY
Yeast two-hybrid screen. Rat GluR6a C-terminal (841E-908A) domain was used as a bait to screen the rat whole-brain complementary DNA library. Dissociated hippocampal cultures. Hippocampal cultures were prepared as previously reported 20 and plated at a density of 500,000 per 60 mm dish or 50,000 onto 22 mm glass coverslips coated with poly-L-lysine.
Biotinylation of cell surface protein. Live hippocampal neurons (21-25 days in vitro) were surface biotinylated on ice using the membrane impermeant Sulfo-NHS-SS-biotin. Fluorescence imaging of GluR6. Live cultured hippocampal neurons (21-25 days in vitro) were transduced with Sinbdis to express appropriate protein constructs. Immunocytochemical imaging of surface and internalized receptors was performed on live and fixed cells using a Zeiss Meta confocal microscope. Electrophysiology. Hippocampal slices were prepared from p14 Wistar rats. Whole-cell patch clamp recordings were made from visually identified CA3 pyramidal neurons and synaptic responses were recorded within 30 s of entering the whole-cell configuration. 
